Our approach to development is reflected in our:

Proven scientific expertise, as reflected in our diversified commercial product portfolio;
Pipeline of novel product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer;
Proprietary science and technology that have the potential to lead to the discovery of new, patentable medicines; and
Commitment to developing new treatment options for major diseases with patient needs in mind.

All this, combined with our highly-skilled employees, our culture of respect for all voices, and our global presence, help position us as a leading innovator in the global biopharmaceutical industry.

Alkermes Downloads

Vivitrol - Naltrexone for Extended-Release Injectable Suspension - Brochure

Bydureon - Model 2mg - Powder and Solvent - Brochure

Risperdal Consta - Benzisoxazole Derivative Tablets - Brochure

Fampyra - Model 10 mg - Prolonged Release Tablets - Brochure